Pembrolizumab, Bevacizumab and Ipilimumab Assays

PPD Laboratories now offers assays for quantitation and detection of pembrolizumab, bevacizumab and ipilimumab, extensively used and clinically successful immuno-oncology therapies. These assays are available for clinical analysis for protocols that include pembrolizumab, bevacizumab and ipilimumab as primary or co-medications.

PPD Bioanalytical Lab owned assays

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2020 PPD, Inc. All Rights Reserved.